These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18868576)

  • 21. [Current status of modern chemotherapy of pulmonary tuberculosis].
    RIOS MOZO M
    Hisp Med; 1954 Jul; 11(121):295-9. PubMed ID: 13201088
    [No Abstract]   [Full Text] [Related]  

  • 22. Various aspects and current status of antibiotic therapy and chemotherapy of pulmonary tuberculosis in adults.
    DE MARTINI A
    Arch Maragliano Patol Clin; 1954; 9(4):863-72. PubMed ID: 13208392
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present aspect of chemotherapy].
    KASSIRSKII IA
    Ter Arkh; 1951; 23(3):95-6. PubMed ID: 14866853
    [No Abstract]   [Full Text] [Related]  

  • 24. [Present situation of chemotherapy].
    HENGEL R
    Med Klin; 1955 Sep; 50(39):1676-8. PubMed ID: 13265192
    [No Abstract]   [Full Text] [Related]  

  • 25. [History and present state of important problems in chemotherapy].
    DEULOFEU V
    Dia Med; 1952 Dec; 24(90):2344-8. PubMed ID: 13033602
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of the utilization of combined interferon chemotherapy in the treatment of laryngeal cancer].
    Bergler W; Bujía J
    Acta Otorrinolaringol Esp; 1994; 45(6):407-10. PubMed ID: 7873228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design.
    Pond GR; Bellmunt J; Rosenberg JE; Bajorin DF; Regazzi AM; Choueiri TK; Qu AQ; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Fougeray R; Wong YN; Sridhar SS; Ko YJ; Milowsky MI; Galsky MD; Sonpavde G
    Clin Genitourin Cancer; 2015 Feb; 13(1):71-9. PubMed ID: 24993933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment.
    Tosi D; Pérez-Gracia E; Atis S; Vié N; Combès E; Gabanou M; Larbouret C; Jarlier M; Mollevi C; Torro A; Del Rio M; Martineau P; Gongora C
    BMC Cancer; 2018 Aug; 18(1):812. PubMed ID: 30103709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy of neoplastic disease; methods of approach.
    KARNOFSKY DA
    N Engl J Med; 1948 Aug; 239(6):226-31. PubMed ID: 18875981
    [No Abstract]   [Full Text] [Related]  

  • 31. [Present state of chemotherapy of bacterial and infectious diseases].
    DENNIG H; HANGLEITER H
    Dtsch Med Wochenschr; 1951 May; 76(20):680-2. PubMed ID: 14849379
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination (synergistic and additive) chemotherapy of syphilis.
    KOLMER JA
    Urol Cutaneous Rev; 1949 Jun; 53(6):338-43. PubMed ID: 18121291
    [No Abstract]   [Full Text] [Related]  

  • 33. [Present and future of chemotherapy].
    NAKARA M; TAKASE Z
    Chiryo; 1963; 45():493-9. PubMed ID: 13932300
    [No Abstract]   [Full Text] [Related]  

  • 34. [The present condition of chemotherapy of cancer].
    LACASSAGNE A
    Medizinische; 1955 May; 21():763-8. PubMed ID: 13244117
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy in perspective; principles of administration in chemotherapy].
    GADDUM JH
    Gaz Med Port; 1950; 3(2):367-74. PubMed ID: 15435761
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy in perspective; principals and practice of local chemotherapy].
    GARROD LP
    Gaz Med Port; 1950; 3(2):359-67. PubMed ID: 15435760
    [No Abstract]   [Full Text] [Related]  

  • 37. [Present tendencies in antibacterial chemotherapy of tuberculosis].
    HINSHAW HC
    Ann Soc R Sci Med Nat Brux; 1953; 6(2):124-32. PubMed ID: 13080849
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergistic antitumour effect of a combination of toremifene and interferon-alpha on ZR-75-1 human breast cancer cells: dependence on interferon-alpha subtype.
    Martin JH; Symonds A
    Oncol Rep; 2002; 9(2):379-82. PubMed ID: 11836612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
    Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
    Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemotherapy of cancer.
    HUGGINS C
    Surg Gynecol Obstet; 1947 Nov; 85(5):660-2. PubMed ID: 20266779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.